Meddenovo transforms drug design through leveraging AI, molecular modelling, and the unique properties of cyclic peptides to create innovative therapeutic solutions.
Meddenovo has raised €1.4M across 2 funding rounds from 2 investors, most recently a round in May 2025. Based in Lyon, France; active in Healthtech. Data as of 7 Aug 2026.
Timing: in window vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date |
|---|
| Stage |
|---|
| Amount |
|---|
| Investors |
|---|
| 2025-05-27 | Other | €396k | INVEST 101 | View deal → |
| 2024-07-31 | Pre-Seed | €1.0M | ACT Venture partners | View deal → |
